REGENXBIO Inc. - RGNX

SEC FilingsOur RGNX Tweets

About Gravity Analytica

Recent News

  • 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
  • 09.09.2025 - Baird 2025 Global Healthcare Conference
  • 09.09.2025 - Baird 2025 Global Healthcare Conference
  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.08.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
  • 09.05.2025 - REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITEĀ® Trial of RGX-121 for Treatment of MPS II
  • 09.05.2025 - REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITEĀ® Trial of RGX-121 for Treatment of MPS II
  • 09.04.2025 - 2025 Wells Fargo Healthcare Conference
  • 09.04.2025 - 2025 Wells Fargo Healthcare Conference

Recent Filings

  • 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 08.18.2025 - EX-99.1 EX-99.1
  • 08.18.2025 - 8-K Current report
  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors